Witnessing the stock’s movement on the chart, on Wednesday, Thermo Fisher Scientific Inc (NYSE: TMO) set off with pace as it heaved 2.79% to $636.3, before settling in for the price of $619.01 at the close. Taking a more long-term approach, TMO posted a 52-week range of $385.46-$629.87.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 12.52%. Meanwhile, its Annual Earning per share during the time was 12.52%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 4.04%. This publicly-traded company’s shares outstanding now amounts to $375.71 million, simultaneously with a float of $374.83 million. The organization now has a market capitalization sitting at $239.06 billion.
Thermo Fisher Scientific Inc (TMO) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Diagnostics & Research industry. Thermo Fisher Scientific Inc’s current insider ownership accounts for 0.23%, in contrast to 91.52% institutional ownership. According to the most recent insider trade that took place on Dec 04 ’25, this organization’s Executive Vice President & COO sold 22,046 shares at the rate of 563.56, making the entire transaction reach 12,424,244 in total value, affecting insider ownership by 84,117. Preceding that transaction, on Dec 03 ’25, Company’s Executive Vice President & COO sold 32,000 for 583.39, making the whole transaction’s value amount to 18,668,526. This particular insider is now the holder of 65,480 in total.
Thermo Fisher Scientific Inc (TMO) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 5.58 per share during the current fiscal year.
Thermo Fisher Scientific Inc’s EPS increase for this current 12-month fiscal period is 4.04% and is forecasted to reach 24.61 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 7.53% through the next 5 years, which can be compared against the 12.52% growth it accomplished over the previous five years trading on the market.
Thermo Fisher Scientific Inc (NYSE: TMO) Trading Performance Indicators
Let’s observe the current performance indicators for Thermo Fisher Scientific Inc (TMO). It’s Quick Ratio in the last reported quarter now stands at 1.11. Alongside those numbers, its PE Ratio stands at $36.77, and its Beta score is 0.92. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.47. Similarly, its price to free cash flow for trailing twelve months is now 39.12.
In the same vein, TMO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 17.31, a figure that is expected to reach 6.45 in the next quarter, and analysts are predicting that it will be 24.61 at the market close of one year from today.
